Related Experiment Videos
Modified immunoprecipitation procedure for the identification of human respiratory syncytial virus polypeptides
Abstract:
When analysed by polyacrylamide gel electrophoresis, human respiratory syncytial virus harvested after a one step growth cycle and purified through a continuous sucrose density gradient was shown to be composed of nine structural proteins of 90, 68, 49, 42, 34, 28, 25, 19 an 13 kd. The 90, 49 and 19 kd polypeptides were identified as glycopolypeptides by glucosamine incorporation. A modified immunoprecipitation procedure confirmed the viral specificity of the 49, 42, 28, 25 and 19 kd polypeptides.
Insights
Human respiratory syncytial virus contains nine structural proteins. Three of these proteins are identified as glycoproteins, with five confirmed as virus-specific using immunoprecipitation.
Area of Science:
- Virology
- Molecular Biology
- Protein Chemistry
Background:
- Human respiratory syncytial virus (HRSV) is a major respiratory pathogen.
- Understanding HRSV's protein composition is crucial for developing antiviral strategies.
Purpose of the Study:
- To characterize the structural proteins of human respiratory syncytial virus.
- To identify viral glycoproteins and confirm protein specificity.
Main Methods:
- Polyacrylamide gel electrophoresis (PAGE) for protein separation.
- Sucrose density gradient centrifugation for virus purification.
- Glucosamine incorporation for glycoprotein identification.
- Modified immunoprecipitation for viral specificity confirmation.
Main Results:
- Nine structural proteins of HRSV were identified, with molecular weights ranging from 13 to 90 kd.
- Proteins of 90, 49, and 19 kd were identified as glycopolypeptides.
- Viral specificity was confirmed for proteins of 49, 42, 28, 25, and 19 kd.
Conclusions:
- The study provides a detailed protein profile of HRSV.
- Identified viral glycoproteins and specific proteins contribute to understanding HRSV structure and function.
- This characterization aids in future research on HRSV pathogenesis and therapeutic development.